Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCellular and Molecular

Inhibition of Multidrug Resistance Proteins by MK 571 Enhances Bladder, Prostate, and Urethra Relaxation through cAMP or cGMP Accumulation

Gabriela Maria Bertollotto, Mariana Gonçalves de Oliveira, Eduardo Costa Alexandre, Fabiano Beraldi Calmasini, Gabriela Reolon Passos, Edson Antunes and Fabiola Zakia Mónica
Journal of Pharmacology and Experimental Therapeutics October 2018, 367 (1) 138-146; DOI: https://doi.org/10.1124/jpet.118.250076
Gabriela Maria Bertollotto
Department of Pharmacology, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariana Gonçalves de Oliveira
Department of Pharmacology, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eduardo Costa Alexandre
Department of Pharmacology, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabiano Beraldi Calmasini
Department of Pharmacology, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriela Reolon Passos
Department of Pharmacology, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edson Antunes
Department of Pharmacology, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabiola Zakia Mónica
Department of Pharmacology, Faculty of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fabiola Zakia Mónica
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    (A–C) Concentration-response curves to MK 571 (1–30 μM) in the isolated bladder (A), prostate (B), and urethra (C) from mice in tissues precontracted with carbachol (1 μM) or phenylephrine (10 μM). Data are the mean ± S.E.M. (n = 4 animals).

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Effect of MK 571 on relaxation responses induced by cAMP- and cGMP-stimulating substances in the isolated bladder. (A–D) Concentration-response curves to isoprenaline (0.001–100 μM; A), fenoterol (0.001–100 μM; B), forskolin (0.01–100 μM; C), and BAY 58-2667 (0.001–10 μM; D) in the absence (control) and presence of MK 571 (20 μM) in tissues precontracted with carbachol (1 μM). Data are the mean ± S.E.M. (n = 4 to 5 animals). *P < 0.05 compared with the control curves.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Intracellular levels of cAMP and p-VASP Ser157 protein expression in the bladder. (A) Intracellular levels of cAMP were determined in unstimulated (basal) tissues and in tissues stimulated with fenoterol (3 μM) or forskolin (100 μM) in the absence and presence of MK 571 (20 μM). Data represent the mean ± S.E.M. (n = 4–6). *P < 0.05; #P < 0.05 compared with fenoterol/forskolin alone and basal, respectively. (B) Expression of p-VASP Ser157 and total VASP was determined in unstimulated (basal) tissues and tissues stimulated with fenoterol (3 μM) alone or in the presence of MK 571 (20 μM). Data are the mean ± S.E.M. (n = 5–7). **P < 0.001 compared with tissues stimulated with fenoterol. DMSO, dimethylsulfoxide.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Effect of MK 571 on relaxation responses induced by cAMP- and cGMP-stimulating substances in the isolated prostate. (A–D) Concentration-response curves to sodium nitroprusside (0.001–100 μM; A), tadalafil (0.001–100 μM; B), 8-Br-cGMP (0.001–100 μM; C), and forskolin (0.001–100 μM; D) in the absence (control) and presence of MK 571 (20 μM) in tissues precontracted with phenylephrine (10 μM). Data are the mean ± S.E.M. (n = 4–7 animals). *P < 0.05; **P < 0.01; ***P < 0.001 compared with the control curves. SNP, sodium nitroprusside.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Effect of MK 571 on relaxation responses induced by cAMP- and cGMP-stimulating substances in the isolated urethra. (A–D) Concentration-response curves to sodium nitroprusside (0.001–100 μM; A), BAY 41-2272 (0.001–1 μM; B), 8-Br-cGMP (0.001–1 μM; C), and forskolin (0.001–100 μM; D) in the absence (control) and presence of MK 571 (20 μM). Data are the mean ± S.E.M. (n = 4–6 animals). *P < 0.05 compared with the control curves. SNP, sodium nitroprusside.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Intracellular levels of cGMP and p-VASP Ser239 protein expression in the prostate. (A) Intracellular levels of cGMP were determined in unstimulated (basal) tissues and in tissues stimulated with sodium nitroprusside (1 μM) or tadalafil (10 μM) in the absence and presence of MK 571 (20 μM). Data are the mean ± S.E.M. (n = 4–7). *P < 0.05 compared with sodium nitroprusside or tadalafil when added alone. (B) Protein expression of p-VASP Ser239 and total VASP was determined in unstimulated (basal) tissues and tissues stimulated with sodium nitroprusside (1 μM) alone or in the presence of MK 571 (20 μM). Data are the mean ± S.E.M. (n = 10–13). **P < 0.0001 compared with tissues stimulated with sodium nitroprusside; #P < 0.05 compared with basal levels. DMSO, dimethylsulfoxide; SNP, sodium nitroprusside.

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 367 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 367, Issue 1
1 Oct 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition of Multidrug Resistance Proteins by MK 571 Enhances Bladder, Prostate, and Urethra Relaxation through cAMP or cGMP Accumulation
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleCellular and Molecular

MRP Inhibition Increases Cyclic Nucleotide Levels in the LUT

Gabriela Maria Bertollotto, Mariana Gonçalves de Oliveira, Eduardo Costa Alexandre, Fabiano Beraldi Calmasini, Gabriela Reolon Passos, Edson Antunes and Fabiola Zakia Mónica
Journal of Pharmacology and Experimental Therapeutics October 1, 2018, 367 (1) 138-146; DOI: https://doi.org/10.1124/jpet.118.250076

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleCellular and Molecular

MRP Inhibition Increases Cyclic Nucleotide Levels in the LUT

Gabriela Maria Bertollotto, Mariana Gonçalves de Oliveira, Eduardo Costa Alexandre, Fabiano Beraldi Calmasini, Gabriela Reolon Passos, Edson Antunes and Fabiola Zakia Mónica
Journal of Pharmacology and Experimental Therapeutics October 1, 2018, 367 (1) 138-146; DOI: https://doi.org/10.1124/jpet.118.250076
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Overview
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Zebrafish Gstp1 drug response
  • Comparison of Piceatannol with Resveratrol
  • Aldosterone synthesis in the heart
Show more Cellular and Molecular

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics